Submitted by Anonymous (not verified) on 12 September 2023 - 15:50
Human medicines European public assessment report (EPAR): Entresto, sacubitril,valsartan, Heart Failure, Date of authorisation: 19/11/2015, Revision: 18, Status: Authorised
Source: